deltatrials
Unknown OBSERVATIONAL NCT04474457

Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age

An ObservationaI Study to Evaluate the Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age Who Are Receiving Favipiravir

Sponsor: Ankara City Hospital Bilkent

Conditions COVID-19
Interventions Favipiravir
Updated 12 times since 2020 Last updated: Jan 29, 2021 Started: Jun 11, 2020 Primary completion: Dec 31, 2020 Completion: Jun 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04474457, this observational or N/A phase trial focuses on COVID-19 and remains ongoing. Sponsored by Ankara City Hospital Bilkent, it has been updated 12 times since 2020, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotRecruiting~Mar 2021 – ~Oct 2021 · 7 months · monthly snapshotActive Not Recruiting~Oct 2021 – ~Feb 2023 · 16 months · monthly snapshotActive Not Recruiting~Feb 2023 – ~Jun 2023 · 4 months · monthly snapshotUnknown Status~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotUnknown~Jan 2025 – ~Jun 2025 · 5 months · monthly snapshotUnknown~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshotUnknown~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshotUnknown~Oct 2025 – present · 9 months · monthly snapshotUnknown

Change History

12 versions recorded
  1. Oct 2025 — Present [monthly]

    Unknown

  2. Sep 2025 — Oct 2025 [monthly]

    Unknown

  3. Jun 2025 — Sep 2025 [monthly]

    Unknown

  4. Jan 2025 — Jun 2025 [monthly]

    Unknown

  5. Sep 2024 — Jan 2025 [monthly]

    Unknown

Show 7 earlier versions
  1. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  2. Jun 2023 — Jul 2024 [monthly]

    Unknown Status

  3. Feb 2023 — Jun 2023 [monthly]

    Unknown Status

    Status: Active Not RecruitingUnknown Status

  4. Oct 2021 — Feb 2023 [monthly]

    Active Not Recruiting

  5. Mar 2021 — Oct 2021 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  6. Jan 2021 — Mar 2021 [monthly]

    Recruiting

  7. Aug 2020 — Jan 2021 [monthly]

    Recruiting

    First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ankara City Hospital Bilkent
  • Ankara Training and Research Hospital
  • Ankara University
  • Derince Training and Research Hospital
  • Ege University Hospital (Application and Research Center)
  • Hacettepe University
  • Istanbul Training and Research Hospital
  • Istanbul University
  • Istanbul University - Cerrahpasa
  • Kayseri City Hospital
  • Ministry of Health, Turkey
  • Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
  • Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
  • Tepecik Training and Research Hospital
  • Umraniye Education and Research Hospital
Data source: Ministry of Health, Turkey

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations